Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors

Eye

Volumn 24, Issue 6, 2010, Pages 1037-1043

  Chang, Y C ^a   Lin, J W ^a   Wang, L C ^a   Chen, H M ^a   Hwang, J J ^a   Chuang, L M ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Hepatic steatosis; Intraocular pressure; Left ventricular mass; Metabolic syndrome; Proteinuria; Risk factor

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EYE EXAMINATION; FATTY LIVER; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; INSULIN RESISTANCE; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PROTEINURIA; RISK FACTOR;

EID: 77953584683     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.247     Document Type: Article

References (43)

1. Lazaro C, Garcia-Feijoo J, Castillo A, Perea J, Martinez-Casa JM, Garcia-Sanchez J. Impact of intraocular pressure after filtration surgery on visual field progression in primary open-angle glaucoma. Eur J Ophthalmol 2007; 17: 357-362.
2. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007; 114: 1965-1972.
3. Civan MM, Macknight AD. The ins and outs of aqueous humour secretion. Exp Eye Res 2004; 78: 625-631.
4. Klein BE, Klein R. Intraocular pressure and cardiovascular risk variables. Arch Ophthalmol 1981; 99: 837-839.
5. Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. The Barbados Eye Study Group. Arch Ophthalmol 1997; 115: 1572-1576.
6. Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma. The Egna-Neumarkt Study. Ophthalmology 2000; 107: 1287-1293.
7. Leske MC, Podgor MJ. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol 1983; 118: 280-287.
8. Dielemans I, Vingerling JR, Algra D, Hofman A, Grobbee DE, de Jong PT. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. Ophthalmology 1995; 102: 54-60.
9. McLeod SD, West SK, Quigley HA, Fozard JL. A longitudinal study of the relationship between intraocular and blood pressures. Invest Ophthalmol Vis Sci 1990; 31: 2361-2366.
10. Leske MC, Warheit-Roberts L, Wu SY. Open-angle glaucoma and ocular hypertension: the Long Island Glaucoma Case-Control Study. Ophthalmic Epidemiol 1996; 3: 85-96.
11. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 1997; 104: 712-718. (Pubitemid 27171997)
12. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older onset diabetes. The Beaver Dam Eye Study. Ophthalmology 1994; 101: 1173-1177.
13. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995; 102: 48-53.
14. Dielemans I, de Jong PT, Stolk R, Vingerling JR, Grobbee DE, Hofman A. Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology 1996; 103: 1271-1275.
15. Shiose S. Intraocular pressure: new perspectives. Surv Ophthalmol 1990; 34: 413-435.
16. Mori K, Ando F, Nomura H, Sato Y, Shimokata H. Relationship between intraocular pressure and obesity in Japan. Int J Epidemiol 2000; 29: 661-666.
17. Lee JS, Lee SH, Oum BS, Chung JS, Cho BM, Hong JW. Relationship between intraocular pressure and systemic health parameters in a Korean population. Clin Experiment Ophthalmol 2002; 30: 237-241.
18. Memarzadeh F, Ying-Lai M, Azen SP, Varma R, Los Angeles Latino Eye Study Group. Associations with intraocular pressure in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2008; 146: 69-76.
19. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1992; 33: 2224-2228.
20. Hennis A, Wu SY, Nemesure B, Leske MC. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 2003; 110: 908-914.
21. Foster PJ, Machin D, Wong TY, Ng TP, Kirwan JF, Johnson GJ et al. Determinants of intraocular pressure and its association with glaucomatous optic neuropathy in Chinese Singaporeans: the Tanjong Pagar Study. Invest Ophthalmol Vis Sci 2003; 44: 3885-3891.
22. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
23. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998; 20: 157-172.
24. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 2003; 290: 932-940.
25. Jacobs Jr DR, Crow RS. Subclinical cardiovascular disease markers applicable to studies of oral health: multiethnic study of atherosclerosis. Ann N Y Acad Sci 2007; 1098: 269-287.
26. Lane HA, Smith JC, Davies JS. Noninvasive assessment of preclinical atherosclerosis. Vasc Health RiskManag 2006; 2: 19-30.
27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
28. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186.
29. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991; 84(3 Suppl): I280-I287.
30. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960. (Pubitemid 17074242)
31. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campbo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparision to necropsy findings. Am J Cardiol 1986; 57: 450-458.
32. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcome in hypertensive patients. Am J Hypertens 2008; 21: 500-508.
33. de Zeeuw D. Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney Int Suppl 2004; 66: S2-S6.
34. Oh SW, Lee S, Park C, Kim DJ. Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab Res Rev 2005; 21: 434-440.
35. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25: 909-920.
36. Yasuda K, Matsunaga T, Adachi T, Aoki N, Tsujimoto G, Tsuda K. Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity. Trends Endocrinol Metab 2006; 17: 269-275.
37. Belmonte C, Bartels SP, Liu JH, Neufeld AH. Effects of stimulation of the ocular sympathetic nerves on IOP and aqueous humor flow. Invest Ophthalmol Vis Sci 1987; 28: 1649-1654.
38. Inagaki Y, Mashima Y, Fuse N, Funayama T, Ohtake Y, Yasuda N et al. Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma. Mol Vis 2006; 12: 673-680.
39. Matias I, Di Marzo V. Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 2007; 18: 27-37.
40. Järvinen T, Pate DW, Laine K. Cannabinoids in the treatment of glaucoma. Pharmacol Ther 2002; 95: 203-220.
41. Verkman AS. Role of aquaporin water channels in eye function. Exp Eye Res 2003; 76: 137-143.
42. MacDougald OA, Burant CF. Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporter. Proc Natl Acad Sci USA 2005; 102: 10759-10760.
43. Hibuse T, Maeda N, Funahashi T, Yamamoto K, Nagasawa A, Mizunoya W et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci USA 2005; 102: 10993-10998.